Emmaus Life Sciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -.--% | +8.58% | -0.10% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.10% | 6.18M | |
+0.14% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.54% | 24.63B | |
-24.44% | 18.2B | |
+26.50% | 12.01B | |
-3.35% | 11.76B | |
+11.19% | 10.4B | |
-1.28% | 9.94B |
- Stock Market
- Equities
- EMMA Stock
- News Emmaus Life Sciences, Inc.
- Emmaus Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt